Long-Term Cost Utility Analysis Of Ideglira Versus Basal-Bolus Insulin Intensification Therapies In Patients With Type 2 Diabetes Inadequately Controlled On Basal Insulin In Spain
Abstract
Authors
M Prades L Lizan B Hunt A Ramirez de Arellano